These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12624783)

  • 1. Expression of CD134 and CD134 ligand in lesional and nonlesional psoriatic skin.
    Matsumura Y; Hori T; Nishigori C; Shirogane K; Toda KI; Uchiyama T; Tanaka Y; Miyachi Y
    Arch Dermatol Res; 2003 Mar; 294(12):563-6. PubMed ID: 12624783
    [No Abstract]   [Full Text] [Related]  

  • 2. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
    Goedkoop AY; Kraan MC; Teunissen MB; Picavet DI; de Rie MA; Bos JD; Tak PP
    Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium.
    Flórido M; Borges M; Yagita H; Appelberg R
    J Leukoc Biol; 2004 Nov; 76(5):1039-46. PubMed ID: 15316035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis.
    Wilde B; Dolff S; Cai X; Specker C; Becker J; Tötsch M; Costabel U; Dürig J; Kribben A; Tervaert JW; Schmid KW; Witzke O
    Nephrol Dial Transplant; 2009 Jan; 24(1):161-71. PubMed ID: 18723571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perforin expression is upregulated in the epidermis of psoriatic lesions.
    Kastelan M; Prpić Massari L; Gruber F; Zamolo G; Zauhar G; Coklo M; Rukavina D
    Br J Dermatol; 2004 Oct; 151(4):831-6. PubMed ID: 15491424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle.
    Burgess JK; Blake AE; Boustany S; Johnson PR; Armour CL; Black JL; Hunt NH; Hughes JM
    J Allergy Clin Immunol; 2005 Feb; 115(2):302-8. PubMed ID: 15696085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD27/CD70, CD134/CD134 ligand, and CD30/CD153 pathways are independently essential for generation of regulatory cells after intratracheal delivery of alloantigen.
    Aramaki O; Shirasugi N; Akiyama Y; Shibutani S; Takayama T; Shimazu M; Kitajima M; Ikeda Y; Okumura K; Yagita H; Niimi M
    Transplantation; 2003 Sep; 76(5):772-6. PubMed ID: 14501851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adult T-cell leukemia and adhesion molecules].
    Imura A; Uchiyama T
    Rinsho Byori; 1996 Sep; Suppl 102():216-21. PubMed ID: 9128094
    [No Abstract]   [Full Text] [Related]  

  • 10. Interleukin-1: a key inflammatory mediator in psoriasis?
    Mee JB; Cork MJ; di Giovine FS; Duff GW; Groves RW
    Cytokine; 2006 Jan; 33(2):72-8. PubMed ID: 16460958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
    Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
    Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.
    Johansen C; Usher PA; Kjellerup RB; Lundsgaard D; Iversen L; Kragballe K
    Br J Dermatol; 2009 Feb; 160(2):319-24. PubMed ID: 19016708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
    Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
    Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis.
    Yawalkar N; Tscharner GG; Hunger RE; Hassan AS
    J Dermatol Sci; 2009 May; 54(2):99-105. PubMed ID: 19264456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions.
    Baker BS; Laman JD; Powles A; van der Fits L; Voerman JS; Melief MJ; Fry L
    J Pathol; 2006 Jun; 209(2):174-81. PubMed ID: 16493599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of IL-1 in the development of autoimmunity].
    Iwakura Y
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2349-54. PubMed ID: 12518460
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
    Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S
    Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intralesional and anatomopathologic features of psoriatic erythroderma].
    Samoud El Kissi S; Cherif Ben Hmida F; Ben Osman Dahri A; Boubacker MS; Hechmi-Louzir M
    Tunis Med; 2007 Jul; 85(7):573-5. PubMed ID: 18064989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
    Markham T; Mullan R; Golden-Mason L; Rogers S; Bresnihan B; Fitzgerald O; Fearon U; Veale DJ
    J Am Acad Dermatol; 2006 Jun; 54(6):1003-12. PubMed ID: 16713454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.